| Related Articles |
UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan.
Jpn J Clin Oncol. 2017 Feb 04;47(2):170-174
Authors: Yoshihama T, Hirasawa A, Nomura H, Akahane T, Nanki Y, Yamagami W, Kataoka F, Tominaga E, Susumu N, Mushiroda T, Aoki D
PMID: 28173214 [PubMed - in process]
http://ift.tt/2lumwRF
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου